Preferred Stock, Shares Authorized of Anixa Biosciences Inc from Q3 2010 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Anixa Biosciences Inc quarterly Preferred Stock, Shares Authorized history and change rate from Q3 2010 to Q2 2025.
  • Anixa Biosciences Inc Preferred Stock, Shares Authorized for the quarter ending 31 Jul 2025 was 19,860, unchanged year-over-year.
Source SEC data
View on sec.gov
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Preferred Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 19,860 0 0% 31 Jul 2025 10-Q 10 Sep 2025 2025 Q3
Q1 2025 19,860 0 0% 30 Apr 2025 10-Q 28 May 2025 2025 Q2
Q4 2024 19,860 0 0% 31 Jan 2025 10-Q 11 Mar 2025 2025 Q1
Q3 2024 19,860 0 0% 31 Oct 2024 10-Q 10 Sep 2025 2025 Q3
Q2 2024 19,860 0 0% 31 Jul 2024 10-Q 06 Sep 2024 2024 Q3
Q1 2024 19,860 0 0% 30 Apr 2024 10-Q 04 Jun 2024 2024 Q2
Q4 2023 19,860 0 0% 31 Jan 2024 10-Q 12 Mar 2024 2024 Q1
Q3 2023 19,860 0 0% 31 Oct 2023 10-K 10 Jan 2025 2024 FY
Q2 2023 19,860 0 0% 31 Jul 2023 10-Q 06 Sep 2023 2023 Q3
Q1 2023 19,860 0 0% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 19,860 0 0% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 19,860 0 0% 31 Oct 2022 10-K 16 Jan 2024 2023 FY
Q2 2022 19,860 0 0% 31 Jul 2022 10-Q 09 Sep 2022 2022 Q3
Q1 2022 19,860 0 0% 30 Apr 2022 10-Q 10 Jun 2022 2022 Q2
Q4 2021 19,860 0 0% 31 Jan 2022 10-Q 11 Mar 2022 2022 Q1
Q3 2021 19,860 0 0% 31 Oct 2021 10-K 04 Jan 2023 2022 FY
Q2 2021 19,860 0 0% 31 Jul 2021 10-Q 01 Sep 2021 2021 Q3
Q1 2021 19,860 30 Apr 2021 10-Q 10 Jun 2021 2021 Q2
Q4 2020 19,860 31 Jan 2021 10-Q 11 Mar 2021 2021 Q1
Q3 2020 19,860 0 0% 31 Oct 2020 10-K 04 Jan 2022 2022 FY
Q2 2020 19,860 31 Jul 2020 10-Q 08 Sep 2020 2020 Q3
Q3 2019 19,860 31 Oct 2019 10-K 07 Jan 2021 2020 FY
Q3 2016 19,860 0 0% 31 Oct 2016 10-K 08 Dec 2016 2016 FY
Q2 2016 19,860 31 Jul 2016 10-Q 19 Aug 2016 2016 Q3
Q3 2015 19,860 31 Oct 2015 10-K 08 Dec 2016 2016 FY
Q2 2014 500,000 0 0% 31 Jul 2014 10-Q 15 Sep 2014 2014 Q3
Q1 2014 500,000 0 0% 30 Apr 2014 10-Q 16 Jun 2014 2014 Q2
Q4 2013 500,000 0 0% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q1
Q3 2013 500,000 0 0% 31 Oct 2013 10-Q 15 Sep 2014 2014 Q3
Q2 2013 500,000 0 0% 31 Jul 2013 10-Q/A 20 Sep 2013 2013 Q3
Q1 2013 500,000 0 0% 30 Apr 2013 10-Q/A 19 Jun 2013 2013 Q2
Q4 2012 500,000 0 0% 31 Jan 2013 10-Q/A 25 Mar 2013 2013 Q1
Q3 2012 500,000 0 0% 31 Oct 2012 10-K/A 17 Jan 2014 2013 FY
Q2 2012 500,000 0 0% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q3
Q1 2012 500,000 30 Apr 2012 10-Q 14 Jun 2012 2012 Q2
Q4 2011 500,000 31 Jan 2012 10-Q 16 Mar 2012 2012 Q1
Q3 2011 500,000 0 0% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 500,000 31 Jul 2011 10-Q/A 14 Oct 2011 2011 Q3
Q3 2010 500,000 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.